Puri Raj K. Insider Trades

Insider Trading History

Track insider trading activity for Puri Raj K.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $515k 117,500 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 117,500 shares
$5.41
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.13M 257,590 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$179k 39,059 shares
$4.58
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.05M 239,230 shares
Last Trade
Mar 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$84.1k 18,360 shares
$4.58
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $342k 78,131 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$179k 39,059 shares
$4.58
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $969k 221,329 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.7k 5,470 shares
$3.79
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $957k 218,531 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.6k 2,798 shares
$3.79
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $95.8k 21,878 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.7k 5,470 shares
$3.79
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $956k 218,326 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2k 5,469 shares
$2.23
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $945k 215,859 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.5k 2,467 shares
$2.23
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $120k 27,348 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2k 5,469 shares
$2.23
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $943k 215,324 shares
Last Trade
Sep 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12k 5,470 shares
$2.19
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $932k 212,857 shares
Last Trade
Sep 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.4k 2,467 shares
$2.19
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $144k 32,817 shares
Last Trade
Sep 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12k 5,470 shares
$2.19
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $930k 212,321 shares
Last Trade
Jun 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.63k 5,469 shares
$1.76
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $168k 38,287 shares
Last Trade
Jun 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.63k 5,469 shares
$1.76
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $919k 209,854 shares
Last Trade
Jun 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.34k 2,467 shares
$1.76
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $906k 206,852 shares
Last Trade
May 23, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.74k 5,600 shares
$1.74
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $892k 203,761 shares
Last Trade
Mar 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.9k 8,334 shares
$3.59
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $881k 201,252 shares
Last Trade
Mar 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.01k 2,509 shares
$3.59
$4.38
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $0 0 shares
Last Trade
Mar 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.9k 8,334 shares
$3.59
$4.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up